FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2967740474> ?p ?o ?g. }

• W2967740474 endingPage "e0218066" @default.
• W2967740474 startingPage "e0218066" @default.
• W2967740474 abstract "The ShangRing is a disposable, collar clamp circumcision device pre-qualified for use in men and boys 13 years and above. It has been shown to be faster than conventional circumcision with comparable adverse event (AE) rates and high client satisfaction. Voluntary medical male circumcision (VMMC) has been shown to dramatically reduce the risk of HIV acquisition in males. However, the fear of pain during circumcision is an important barrier to uptake. Use of topical anesthesia thus presents an opportunity to address this.We sought to evaluate the safety, effectiveness and acceptability of the use of topical anaesthesia with ShangRing circumcision of men and boys 10 years of age and above.Participants were randomised 2:1 to receive topical or injectable anaesthesia. All participants underwent no-flip ShangRing circumcision. The primary outcome measure was pain. Secondary outcomes included ease of use of topical versus injectable anaesthesia, AEs and participant satisfaction.Compared to the topical group, participants in the injectable group reported significantly more pain on administration of the anesthesia and at approximately 20 minutes after the procedure. In the topical group, sufficient anaesthesia with topical cream was not achieved in 21 (9.3%) cases before the start of the procedure; in another 6 (2.6%), supplementary injectable anaesthesia was required as the circumcision was being carried out. The AE rate was significantly lower (p<0.01) in the topical (0%) vs. the injectable group (4.2%). The most common AE was pain during the post-operative period. All AEs were managed conservatively and resolved without sequeale. 96.7% of participants were satisfied with the appearance of the healed penis and 100% would recommend the ShangRing to others. All seven male circumcision providers involved in the study preferred topical to injectable anaesthesia.Our results demonstrate the safety, improved clinical experience, effectiveness, and acceptability of the use of topical anaesthesia in ShangRing circumcision using the no-flip technique. Topical anaesthesia effectively eliminates needlestick pain from the clients' VMMC experience and thus has the potential to increase demand for the service.ClinicalTrials.gov NCT02390310." @default.
• W2967740474 created "2019-08-22" @default.
• W2967740474 creator A5010128455 @default.
• W2967740474 creator A5014233171 @default.
• W2967740474 creator A5016409586 @default.
• W2967740474 creator A5019252348 @default.
• W2967740474 creator A5023142542 @default.
• W2967740474 creator A5027514811 @default.
• W2967740474 creator A5037841863 @default.
• W2967740474 creator A5045049304 @default.
• W2967740474 creator A5051004762 @default.
• W2967740474 creator A5063174259 @default.
• W2967740474 creator A5064283574 @default.
• W2967740474 creator A5064551275 @default.
• W2967740474 creator A5065067980 @default.
• W2967740474 creator A5068634923 @default.
• W2967740474 creator A5072272493 @default.
• W2967740474 creator A5078555143 @default.
• W2967740474 creator A5091672511 @default.
• W2967740474 date "2019-08-14" @default.
• W2967740474 modified "2023-10-14" @default.
• W2967740474 title "Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial" @default.
• W2967740474 cites W1995920680 @default.
• W2967740474 cites W1999250349 @default.
• W2967740474 cites W2018407092 @default.
• W2967740474 cites W2022650097 @default.
• W2967740474 cites W2024261708 @default.
• W2967740474 cites W2034419817 @default.
• W2967740474 cites W2035411558 @default.
• W2967740474 cites W2037087763 @default.
• W2967740474 cites W2040639827 @default.
• W2967740474 cites W2044069756 @default.
• W2967740474 cites W2055998805 @default.
• W2967740474 cites W2056260400 @default.
• W2967740474 cites W2079002045 @default.
• W2967740474 cites W2086296139 @default.
• W2967740474 cites W2092418202 @default.
• W2967740474 cites W2094447298 @default.
• W2967740474 cites W2115373328 @default.
• W2967740474 cites W2132165717 @default.
• W2967740474 cites W2143071104 @default.
• W2967740474 cites W2146428988 @default.
• W2967740474 cites W2148207513 @default.
• W2967740474 cites W2431026329 @default.
• W2967740474 cites W2463855032 @default.
• W2967740474 cites W2465573248 @default.
• W2967740474 cites W2467276204 @default.
• W2967740474 cites W2472796662 @default.
• W2967740474 cites W2735435991 @default.
• W2967740474 cites W4247415371 @default.
• W2967740474 cites W5695563 @default.
• W2967740474 doi "https://doi.org/10.1371/journal.pone.0218066" @default.
• W2967740474 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6693766" @default.
• W2967740474 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31412032" @default.
• W2967740474 hasPublicationYear "2019" @default.
• W2967740474 type Work @default.
• W2967740474 sameAs 2967740474 @default.
• W2967740474 citedByCount "1" @default.
• W2967740474 countsByYear W29677404742020 @default.
• W2967740474 crossrefType "journal-article" @default.
• W2967740474 hasAuthorship W2967740474A5010128455 @default.
• W2967740474 hasAuthorship W2967740474A5014233171 @default.
• W2967740474 hasAuthorship W2967740474A5016409586 @default.
• W2967740474 hasAuthorship W2967740474A5019252348 @default.
• W2967740474 hasAuthorship W2967740474A5023142542 @default.
• W2967740474 hasAuthorship W2967740474A5027514811 @default.
• W2967740474 hasAuthorship W2967740474A5037841863 @default.
• W2967740474 hasAuthorship W2967740474A5045049304 @default.
• W2967740474 hasAuthorship W2967740474A5051004762 @default.
• W2967740474 hasAuthorship W2967740474A5063174259 @default.
• W2967740474 hasAuthorship W2967740474A5064283574 @default.
• W2967740474 hasAuthorship W2967740474A5064551275 @default.
• W2967740474 hasAuthorship W2967740474A5065067980 @default.
• W2967740474 hasAuthorship W2967740474A5068634923 @default.
• W2967740474 hasAuthorship W2967740474A5072272493 @default.
• W2967740474 hasAuthorship W2967740474A5078555143 @default.
• W2967740474 hasAuthorship W2967740474A5091672511 @default.
• W2967740474 hasBestOaLocation W29677404741 @default.
• W2967740474 hasConcept C126322002 @default.
• W2967740474 hasConcept C141071460 @default.
• W2967740474 hasConcept C168563851 @default.
• W2967740474 hasConcept C197934379 @default.
• W2967740474 hasConcept C2775944032 @default.
• W2967740474 hasConcept C2776983577 @default.
• W2967740474 hasConcept C42219234 @default.
• W2967740474 hasConcept C71924100 @default.
• W2967740474 hasConceptScore W2967740474C126322002 @default.
• W2967740474 hasConceptScore W2967740474C141071460 @default.
• W2967740474 hasConceptScore W2967740474C168563851 @default.
• W2967740474 hasConceptScore W2967740474C197934379 @default.
• W2967740474 hasConceptScore W2967740474C2775944032 @default.
• W2967740474 hasConceptScore W2967740474C2776983577 @default.
• W2967740474 hasConceptScore W2967740474C42219234 @default.
• W2967740474 hasConceptScore W2967740474C71924100 @default.
• W2967740474 hasFunder F4320306137 @default.
• W2967740474 hasIssue "8" @default.
• W2967740474 hasLocation W29677404741 @default.
• W2967740474 hasLocation W29677404742 @default.

• next